Early-Stage Researcher

Partner Lab

The Friedrich Miescher Institute (FMI) for Biomedical Research is a premier institute for fundamental biomedical research aiming at understanding the molecular mechanisms of health and diseases. FMI specializes in epigenetics of stem cell development and cell differentiation, mechanisms of cancer, including signalling pathways and neurobiology. FMI has international recognition as a centre of excellence in innovative biomedical research. FMI is also dedicated to the training of graduate students and postdoctoral fellows, affiliated with the University of Basel, where graduate students are enrolled and where it contributes to the teaching program.


Originally from Kraków, Poland, Zuzanna graduated from the University of Edinburgh in July 2018 with an Integrated Masters degree in Medicinal and Biological Chemistry. During her degree, she completed a year-long internship with Prof. Nenad Ban at ETH Zurich working on telomerase expression and purification for structural studies. She has also done summer projects at the Institut Laue-Langevin in Grenoble and in Prof. Mark Bradley’s group at the University of Edinburgh. Enticed by her recent research project with Prof. Alessio Ciulli at the University of Dundee, during which she studied the behaviour of heterobifunctional degraders using computational methods, Zuzanna applied to join the group of Dr Nicolas Thomä to continue working on proteolysis targeting chimeras but in a structural/chemical biology context. Her PhD project will focus on developing novel classes of small molecules to degrade proteins of therapeutic interest.